New patent expiration for Novartis drug VOTRIENT – DrugPatentWatch

Annual Drug Patent Expirations for VOTRIENT

Votrient is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There is one patent protecting this drug.

This drug has thirty-four patent family members in twenty-five countries.

The generic ingredient in VOTRIENT is pazopanib hydrochloride. One supplier is listed for this compound. Additional details are available on the pazopanib hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com